Good Faith Exam for GLP-1 Clinics: What Prescribing Actually Requires

Table of Contents

A good faith exam for GLP-1 clinics requires a licensed provider to evaluate a patient’s metabolic history, contraindications, and current medications before writing a prescription. State medical boards are now scrutinizing clinics that skipped that evaluation to move faster. Semaglutide, tirzepatide, and every other GLP-1 medication are prescription drugs, and they carry the same evaluation standard as any other prescription treatment.

Key takeaways

  • GLP-1 medications require an individualized exam before prescribing, not a subscription intake form. (Jump to Section)
  • The exam must cover metabolic history, contraindications, and current medications relevant to GLP-1 therapy. (Jump to Section)
  • Ongoing monitoring, not just the initial visit, is part of the compliant prescribing standard. (Jump to Section)

Why the Subscription Model Draws Scrutiny

Many GLP-1 telehealth subscriptions run on a static questionnaire. A patient checks boxes, and a prescription follows within minutes, with no licensed provider reviewing the answers in real time. That setup skips the step regulators care about most, which is an actual patient-provider relationship.

The American Med Spa Association has flagged this exact pattern across the aesthetics and wellness industry, and GLP-1 clinics now sit under that scrutiny. An intake form only documents what a patient reports. It doesn’t show that a provider evaluated the risk and made an independent clinical judgment. A good faith exam exists to prove that judgment occurred.

What the GLP-1 Good Faith Exam Should Cover

A compliant GLP-1 good faith exam has to document specific clinical findings before a provider can justify a prescription. Skipping any one of these findings leaves the prescription without a documented clinical basis. The following four categories set the minimum standard for that documentation.

  • Metabolic and endocrine history: The exam should record thyroid function, diabetes status, and any prior weight-related diagnoses.
  • Contraindications: The provider should screen for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, along with a history of pancreatitis.
  • Current medications: The exam should list anything that could interact with a GLP-1 agonist, including other diabetes or weight management drugs.
  • Weight and treatment history: The exam should note prior weight loss attempts, other medical weight loss treatments, and any bariatric procedures.

A self-reported checkbox list cannot satisfy this standard because none of these four findings carry clinical weight on their own. A provider has to interpret them together, follow up where the history is incomplete, and document the reasoning behind the final decision to prescribe.

This Doesn’t End at the First Prescription

The good faith exam that clears a patient for a first prescription doesn’t cover the months of dose titration that follow. Side effects shift as the dose increases, and state frameworks tie the good faith exam to specific reassessment triggers. At each one, the provider has to reconfirm that the patient is still an appropriate candidate for the dose in use.

  • Side effect changes: Nausea, gastrointestinal symptoms, and injection site reactions can intensify or shift as the dose increases.
  • Annual renewal: Most state frameworks require the good faith exam to renew at least once a year.
  • Health status changes: A new diagnosis, medication, or condition triggers an early re-exam regardless of the renewal schedule.
  • New treatment additions: Adding a different weight management therapy to the regimen requires its own updated evaluation.

Skipping any of these triggers turns a compliant good faith exam into an outdated one, and an outdated exam carries the same enforcement risk as never performing one at all. A weight loss clinic compliance program schedules these reassessments before they’re due, instead of waiting for a renewal deadline or a complaint to force the issue.

Is Your Medical Director Actually Reviewing Exams?

Medical Director Co. places physicians who tie every good faith exam to a documented, state-specific delegation agreement.

Who Can Prescribe GLP-1 Medications in This Setting

A physician, nurse practitioner, or physician assistant with prescriptive authority can prescribe GLP-1 medications, provided the exam and the prescribing decision come from that licensed provider directly. Registered nurses can assist with intake and documentation, but they cannot perform the exam or generate the treatment order. Delegation rules for that authority vary sharply by state, and no single national standard applies.

  • Arizona: Nurse practitioners have full practice authority and can evaluate, diagnose, and prescribe independently without a supervising physician’s sign-off.
  • Arkansas, Kentucky, and Louisiana: Nurse practitioners need a career-long collaborative agreement with a physician before they can prescribe.
  • Texas: The framework ties prescribing to physician supervision and specific telemedicine rules for the initial evaluation.
  • Florida: The patient-provider relationship can form through telehealth, but clinics must meet strict documentation standards on the back end.
  • California: A documented, appropriate prior examination is required before any part of the visit can be delegated, a standard tied to the state’s Business and Professions Code.

A clinic operating in more than one state needs a separate protocol for each one, because a delegation model that’s compliant in Arizona can amount to unauthorized practice in Arkansas or Kentucky. The delegation rules for GLP-1 prescribing largely mirror those for other delegated treatments.

How Medical Director Co. Supports Compliant GLP-1 Programs

Medical Director Co. matches a GLP-1 clinic with a licensed physician who reviews the good faith exam protocol before the clinic evaluates its first patient. The placement includes a written delegation agreement naming who can perform the exam, a documented exam and renewal schedule matched to the clinic’s state, and a physician who reviews charts on an ongoing basis. That physician also updates the protocol when the clinic adds a new state, a new provider, or a new treatment, so the delegation agreement stays current.

FAQ

Can a patient get a GLP-1 prescription from a form alone?

A form-only intake without a real provider evaluation does not establish a valid patient-provider relationship, so a prescription issued from it is not legally sound. The prescription that follows carries the same risk as one written without a good faith exam at all. Regulators treat this gap as a first-line audit issue, not a technicality.

What should a GLP-1 clinic’s exam specifically screen for?

The good faith exam should screen for metabolic and endocrine history, contraindications such as a personal or family history of certain thyroid cancers, and current medications that could interact with the therapy. A provider who skips any of these categories cannot justify the prescribing decision if a board later requests the chart.

Does GLP-1 prescribing require ongoing visits?

Dose adjustments and monitoring for side effects are part of the standard of care, so a single evaluation at intake does not cover a patient through months of titration. Providers typically re-evaluate the patient at each dose change, not only at the annual renewal date.

Who can prescribe GLP-1 medications for weight loss?

A physician, nurse practitioner, or physician assistant with prescriptive authority can prescribe GLP-1 medications, following the delegation rules that apply in that provider’s state. Registered nurses can support the visit but cannot write the prescription.

Why are regulators paying closer attention to GLP-1 clinics specifically?

The rapid rise of subscription telehealth weight loss services drew scrutiny to a model that skipped individualized provider evaluation in favor of speed. That scrutiny now extends to how clinics document delegation and ongoing monitoring, not just the initial visit.

Closing the Compliance Gap Before a Board Finds It

A compliant GLP-1 program rests on three connected records: the good faith exam, the delegation agreement, and the monitoring schedule. When clinics get flagged, it’s usually because they stopped updating the monitoring schedule after intake. So, check all three against your own clinic’s file before your next patient starts treatment.

One Weak Record Is All It Takes.

Talk to Medical Director Co. about a physician placement built around your state's exam and delegation requirements.

bolton-harris

Bolton M. Harris, J.D.

is a seasoned attorney with a formidable background in criminal law and a focus on healthcare law and compliance. As the in-house legal counsel at Medical Director Co., Harris brings a unique blend of prosecutorial experience and regulatory expertise to support healthcare professionals across Texas. Her career spans roles as a prosecutor in multiple counties and now as a trusted advisor on the legal intricacies of medical practice operations.

Related Articles

Hire a Medical Director or
Collaborating Physician Today

Scroll to Top

Get Matched Today
and Save $200

We'll contact you within 30 minutes.

Select your clinic type and we’ll match you with the right physician — fast.

Medspa/Aesthetics

Weight Loss

IV/Wellness

Telehealth

Other

Your clinic type:

Medspa/Aesthetics
Change Clinic Type

You're on your way!

We received your request for a physician.
Our team will contact you soon.